Elekta AB ROE 2013-2025 | EKTAY
Current and historical return on equity (ROE) values for Elekta AB (EKTAY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Elekta AB ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-01-31 | $0.10B | $0.99B | 9.66% |
| 2024-10-31 | $0.10B | $1.01B | 9.46% |
| 2024-07-31 | $0.11B | $1.01B | 10.73% |
| 2024-04-30 | $0.12B | $1.01B | 12.38% |
| 2024-01-31 | $0.13B | $0.99B | 14.01% |
| 2023-10-31 | $0.13B | $0.94B | 13.41% |
| 2023-07-31 | $0.11B | $0.97B | 11.58% |
| 2023-04-30 | $0.09B | $0.93B | 10.01% |
| 2023-01-31 | $0.08B | $0.92B | 9.05% |
| 2022-10-31 | $0.09B | $0.85B | 9.30% |
| 2022-07-31 | $0.12B | $0.90B | 15.40% |
| 2022-04-30 | $0.13B | $1.00B | 16.09% |
| 2022-01-31 | $0.12B | $0.99B | 15.66% |
| 2021-10-31 | $0.14B | $0.22B | 17.41% |
| 2021-07-31 | $0.14B | $0.99B | 14.17% |
| 2021-04-30 | $0.14B | $0.94B | 15.63% |
| 2021-01-31 | $0.15B | $0.98B | 16.39% |
| 2020-10-31 | $0.14B | $0.91B | 16.23% |
| 2020-07-31 | $0.12B | $0.84B | 14.31% |
| 2020-04-30 | $0.11B | $0.84B | 13.51% |
| 2020-01-31 | $0.13B | $0.86B | 15.45% |
| 2019-10-31 | $0.12B | $0.81B | 14.63% |
| 2019-07-31 | $0.13B | $0.83B | 15.92% |
| 2019-04-30 | $0.13B | $0.86B | 16.54% |
| 2019-01-31 | $0.14B | $0.80B | 16.77% |
| 2018-10-31 | $0.15B | $0.77B | 18.19% |
| 2018-07-31 | $0.15B | $0.78B | 17.76% |
| 2018-04-30 | $0.13B | $0.96B | 15.62% |
| 2018-01-31 | $0.08B | $0.85B | 9.82% |
| 2017-10-31 | $0.05B | $0.83B | 6.12% |
| 2017-07-31 | $0.02B | $0.76B | 2.93% |
| 2017-04-30 | $0.01B | $0.78B | 1.85% |
| 2017-01-31 | $0.01B | $0.71B | 1.59% |
| 2016-10-31 | $0.01B | $0.77B | 0.92% |
| 2016-07-31 | $0.02B | $0.78B | 2.98% |
| 2016-04-30 | $0.02B | $0.76B | 1.92% |
| 2016-01-31 | $0.05B | $0.75B | 5.65% |
| 2015-10-31 | $0.06B | $0.79B | 7.73% |
| 2015-07-31 | $0.07B | $0.82B | 8.25% |
| 2015-04-30 | $0.07B | $0.90B | 7.43% |
| 2015-01-31 | $0.14B | $0.81B | 16.16% |
| 2014-10-31 | $0.15B | $0.83B | 16.59% |
| 2014-07-31 | $0.15B | $0.97B | 17.04% |
| 2014-04-30 | $0.17B | $0.96B | 19.94% |
| 2014-01-31 | $0.18B | $0.81B | 21.80% |
| 2013-10-31 | $0.19B | $0.78B | 24.06% |
| 2013-07-31 | $0.20B | $0.84B | 25.78% |
| 2013-04-30 | $0.20B | $0.84B | 27.51% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.975B | $1.708B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.668B | 87.45 |
| Thermo Fisher Scientific (TMO) | United States | $151.715B | 18.35 |
| Edwards Lifesciences (EW) | United States | $45.473B | 29.82 |
| Alcon (ALC) | Switzerland | $43.302B | 29.26 |
| IDEXX Laboratories (IDXX) | United States | $42.214B | 48.51 |
| DexCom (DXCM) | United States | $33.984B | 52.53 |
| IQVIA Holdings (IQV) | United States | $26.351B | 14.76 |
| Mettler-Toledo (MTD) | United States | $24.614B | 29.27 |
| STERIS (STE) | Ireland | $23.975B | 26.41 |
| Waters (WAT) | United States | $20.898B | 29.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.583B | 0.00 |
| Hologic (HOLX) | United States | $14.336B | 15.58 |
| Sysmex ADR (SSMXY) | Japan | $10.191B | 28.91 |
| Penumbra (PEN) | United States | $10.026B | 78.69 |
| Masimo (MASI) | United States | $9.324B | 34.39 |
| Globus Medical (GMED) | United States | $8.112B | 19.33 |
| Teleflex (TFX) | United States | $5.426B | 8.96 |
| Glaukos (GKOS) | United States | $5.314B | 0.00 |
| TransMedics (TMDX) | United States | $4.703B | 102.24 |
| Integer Holdings (ITGR) | United States | $4.233B | 22.18 |
| PROCEPT BioRobotics (PRCT) | United States | $3.481B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.505B | 14.92 |
| Veracyte (VCYT) | United States | $2.151B | 30.18 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 23.53 |
| Alphatec Holdings (ATEC) | United States | $1.861B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.384B | 0.00 |
| Artivion (AORT) | United States | $1.236B | 115.80 |
| Pulse Biosciences (PLSE) | United States | $1.150B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.054B | 5.60 |
| Beta Bionics (BBNX) | United States | $0.827B | 0.00 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| IRadimed (IRMD) | United States | $0.769B | 39.03 |
| RxSight (RXST) | United States | $0.611B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.576B | 8.96 |
| Delcath Systems (DCTH) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.567B | 13.30 |
| OrthoPediatrics (KIDS) | United States | $0.515B | 0.00 |
| AxoGen (AXGN) | United States | $0.497B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.390B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.368B | 9.79 |
| Treace Medical Concepts (TMCI) | United States | $0.365B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.342B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Neuronetics (STIM) | United States | $0.245B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.14 |
| Sight Sciences (SGHT) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.213B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.200B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| CVRx (CVRX) | United States | $0.171B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.116B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 49.20 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.29 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |